3/18
09:00 am
iron
Rating for IRON
Low
Report
Rating for IRON
3/7
12:26 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $85.00 price target on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $85.00 price target on the stock.
3/7
12:26 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $85.00 price target on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $85.00 price target on the stock.
3/7
12:23 pm
iron
Rating for IRON
Low
Report
Rating for IRON
3/7
12:23 pm
iron
Rating for IRON
Low
Report
Rating for IRON
3/3
10:00 am
iron
Rating for IRON
Low
Report
Rating for IRON
3/3
10:00 am
iron
Rating for IRON
Low
Report
Rating for IRON
1/24
10:38 am
iron
Rating for IRON
Low
Report
Rating for IRON
1/22
08:54 am
iron
Rating for IRON
Low
Report
Rating for IRON
1/22
08:54 am
iron
Rating for IRON
Low
Report
Rating for IRON
1/21
01:17 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $118.00 price target on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $118.00 price target on the stock.
1/21
12:15 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $90.00 price target on the stock, up previously from $83.00.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $90.00 price target on the stock, up previously from $83.00.
1/21
12:15 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $90.00 price target on the stock, up previously from $83.00.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $90.00 price target on the stock, up previously from $83.00.